4.7 Review

In vivo therapeutic applications of phosphorus dendrimers: state of the art

Journal

DRUG DISCOVERY TODAY
Volume 26, Issue 3, Pages 677-689

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.11.034

Keywords

-

Funding

  1. PRC NSFC-CNRS 2019 [21911530230, 199675]
  2. ARDITIAgencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao [M1420-01-0145FEDER-000005-CQM+]
  3. EuroNanoMed III
  4. Spanish Ministerio de Economia y Competitividad (MINECO/AEI/FEDER/UE) [SAF201789288-R]
  5. JCCM [SBPLY/19/180501/000067]
  6. CNRS (France)
  7. Polish National Agency for Academic Exchange, grant EUROPARTNER [PPI/APM/2018/1/00007/U/001]
  8. Belarusian Republican Foundation for Fundamental Research and State Committee of Science and Technology of Belarus [B19ARMG-002, B20SLKG-002]
  9. FCT-Fundacao para a Ciencia e a Tecnologia (Base Fund) [UIDB/00674/2020]
  10. FCT-Fundacao para a Ciencia e a Tecnologia (Programmatic Fund, Portuguese Government Funds) [UIDP/00674/2020]

Ask authors/readers for more resources

Among the different types of dendrimers, those that incorporate phosphorus in various positions in their structures present fascinating properties and have wide applications in pharmaceutical fields such as drug delivery (including gene transfection), diagnosis and imaging. Therapeutic agents can be encapsulated within the dendritic architecture, or chemically attached or physically adsorbed onto the dendrimer surface. Alternatively, phosphorus dendrimers can be developed as drugs themselves, for instance to treat cancer, inflammations, infections and neurodegenerative diseases, although there are fewer examples of this second approach. Here, we review the most relevant in vivo biological activities of phosphorus dendrimers (whether as active drugs per se or as nanocarriers) across various therapeutic domains, including anti inflammation, transmissible spongiform encephalopathies, ocular hypertension, infection, gene therapy, ultrasound-targeted microbubble destruction and two-photon in vivo imaging. We discuss the success of phosphorus dendrimers in nanomedicine and look ahead to future innovations in the field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available